$706 Million is the total value of Vivo Capital, LLC's 34 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 28.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SBBP | Sell | Strongbridge Biopharma plc | $16,975,000 | -4.5% | 1,918,132 | -21.8% | 2.40% | -36.8% |
KALA | Sell | Kala Pharmaceuticals, Inc. | $16,511,000 | -22.9% | 1,043,020 | -10.0% | 2.34% | -49.0% |
AIMT | Sell | Aimmune Therapeutics, Inc. | $9,768,000 | -59.9% | 306,872 | -52.3% | 1.38% | -73.5% |
ZLAB | Sell | Zai Lab LTDadr | $6,059,000 | -10.1% | 283,787 | -10.6% | 0.86% | -40.6% |
SNSS | Sell | Sunesis Pharmaceuticals, Inc. | $532,000 | -71.2% | 195,474 | -60.9% | 0.08% | -81.0% |
CRSP | Exit | CRISPR Therapeutics AGnamen akt | $0 | – | -98,511 | -100.0% | -0.50% | – |
AAAP | Exit | Advanced Accelerator Applications S.A.ads | $0 | – | -249,241 | -100.0% | -4.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
CODEXIS INC | 29 | Q3 2023 | 8.0% |
ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
AMYRIS INC | 23 | Q3 2023 | 8.8% |
EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-22 |
13F-HR | 2024-02-07 |
13F-HR | 2023-11-08 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.